Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Bullboard Posts
Post by gemsearcher2on Feb 01, 2010 10:54pm
221 Views
Post# 16742183

Interesting times for SDI

Interesting times for SDII was not aware that the meeting was delayed and was looking foreward to the finalization in writing!..So...this throws a bit of  a different light on things....maybe some changes will come about to the agreement.

I was glad to see the spike a few weeks ago,and wondered what the retracement would be.Still not sure where it'll end up,but with timelines running along,we have to believe that things are getting done behind the scenes.
Obviously,SDI's story will not be kept under wraps in North America forever,so waiting a bit longer for some guidance will not bother me too much,and am looking foreward to what they have to tell us.
Bullboard Posts